Sign In
Buy RIGL
$30.30
+0.280 (+0.93%)
At Close: Jun 03, 2026
Rigel Pharmaceuticals Provides Business Update
08:05am, Monday, 08'th Jan 2024
Preliminary fourth quarter 2023 total revenue of approximately $35.7 million which includes record TAVALISSE® net product sales of $25.7 million and REZLIDHIA® net product sales of $3.9 million Stra
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
04:30pm, Friday, 05'th Jan 2024
SOUTH SAN FRANCISCO, Calif. , Jan. 5, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to Rigel's Inducement Plan, approved
Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma
08:05am, Thursday, 04'th Jan 2024
SOUTH SAN FRANCISCO, Calif. , Jan. 4, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced a collaboration with CONNECT, an international collaborative network of pediatri
Here's Why You Should Bet on Rigel Pharmaceuticals (RIGL) Now
12:01pm, Wednesday, 03'rd Jan 2024
Here, we discuss some reasons why buying Rigel Pharmaceuticals (RIGL) stock now may turn out to be a prudent move.
Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
08:05am, Wednesday, 03'rd Jan 2024
SOUTH SAN FRANCISCO, Calif. , Jan. 3, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and CEO, will present a company overv
Best Momentum Stock to Buy for December 8th
11:16am, Friday, 08'th Dec 2023
BRSP and RIGL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 8, 2023.
Rigel Pharmaceuticals: Push To Profitability Continues, But COVID Beacon Seems Extinguished
07:09pm, Thursday, 30'th Nov 2023
RIGL's net loss continues to narrow, down to $5.7M in Q3'23. RIGL's patent infringement suit with Annora Pharma is in play, but I don't expect a near-term issue on Tavalisse market exclusivity, becaus
New Strong Buy Stocks for November 28th
07:31am, Tuesday, 28'th Nov 2023
AQST, BROS, NSSC, RIGL and RBT have been added to the Zacks Rank #1 (Strong Buy) List on November 28, 2023.
Best Momentum Stocks to Buy for November 22nd
11:17am, Wednesday, 22'nd Nov 2023
BWAY, RIGL and BROS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 22, 2023.
New Strong Buy Stocks for November 22nd
07:31am, Wednesday, 22'nd Nov 2023
RIGL, BWAY, AVDX, IMGN and EAT have been added to the Zacks Rank #1 (Strong Buy) List on November 22, 2023.
Rigel Pharmaceuticals, Inc. (RIGL) Q3 2023 Earnings Call Transcript
06:26pm, Tuesday, 07'th Nov 2023
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Ray Furey - Executive Vice President, General Counsel & Corporate Secretary
Rigel to Present at the Jefferies London Healthcare Conference
08:05am, Monday, 06'th Nov 2023
SOUTH SAN FRANCISCO, Calif. , Nov. 6, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, will present a company o
Rigel to Present at the 2023 Cantor Global Healthcare Conference
08:05am, Wednesday, 20'th Sep 2023
SOUTH SAN FRANCISCO, Calif. , Sept. 20, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, will present a company
Rigel to Participate in Upcoming September Investor Conferences
08:05am, Wednesday, 30'th Aug 2023
SOUTH SAN FRANCISCO, Calif. , Aug. 30, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, and De
Rigel Pharmaceuticals, Inc. (RIGL) Q2 2023 Earnings Call Transcript
09:58pm, Tuesday, 01'st Aug 2023
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Ray Furey - EVP, General Counsel and Corporate Secretary. Raul Rodriguez - Pr
